The association of HLA-A, -B, and -DRB1 genotypes with Graves' disease in Taiwanese people

Tissue Antigens

Volumn 61, Issue 2, 2003, Pages 154-158

  Huang, Shih Ming ^a   Wu, T J ^b   Lee, T D ^a   Yang, E K L ^a   Shaw, C K ^a   Yeh, C C ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Graves' disease; Graves' ophthalmopathy; HLA typing; PCR SSOP; Susceptibility genes

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; OLIGONUCLEOTIDE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOCRINE OPHTHALMOPATHY; FEMALE; GENE LOCUS; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HAPLOTYPE; HLA SYSTEM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; TAIWAN;

EID: 0038218263     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2003.00016.x     Document Type: Article

References (31)

1. Lee A, Huang R, Yan L et al. Heterogeneity of HLA-DR2 haplotypes in Caucasoid Americans, African Americans, Chinese Americans, Native Americans and Xiamen Chinese. Eur J Immunogenet 1999: 26: 275-80.
2. Lee TD, Lee A, Lai S, Huang R, Yan L, Lee G. An apparent functional correlation between variations in amino acid residues in HLA-DR4.1 and 4.2 serological subtypes and oligonucleotide characterization. Eur J Immunogenet 1996: 23: 129-40.
3. Lee TD, Yang KL, Lin P-Y, Shaw CK, Lee A. Outcome of UBMT using DNA vs serological technique in Tzu Chi marrow D program. In: Proceedings of the 10th Regional Congress of the International Society of Blood Transfusion Western Pacific Region. Taipei: Taiwan Society of Blood Transfusion, 2000: 78-81.
4. Badenhoop K, Walfish PG, Rau H et al. Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are shared in endocrine autoimmune disease. J Clin Endocrinol Metab 1995: 80: 2112-7.
5. Cuddihy RM, Balm RS. Lack of an independent association between the human leukocyte antigen allde DQA1*0501 and Graves' disease. J Clin Endocrinol Metab 1996: 81: 847-9.
6. Onuma H, Ota M, Sugenoya A, Inokp H. Association of HLA-DPB1*0501 with early-onset Graves' disease in Japanese. Hum Immunol 1994: 39: 195-201.
7. Van Dyk HJL. Orbital Graves' disease a modification of the 'NO SPECS'classification. Ophthalmology 1981: 88: 479-83.
8. Costagliola S, Morgenthaler NG, Hoermann R et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 1999: 84: 90-7.
9. Klein J, Sato A. The HLA system. New Engl J Med 2000: 343: 782-6.
10. Gilbert SC, Plebanski M, Gupta S et al. Association of malaria parasite population structure, HLA, and immunological antagonism. Science 1998: 279: 1173-7.
11. Amagi M. Autoimmunity against desmosomal cadherins in pemphigns. J Dermatol Sci 1999: 20: 92-102.
12. Kendall-Taylor P, Stephenson A, Stratton A, Papiha SS, Perros P, Roberts DF. Differentiation of autoimmune ophthalmopathy from Graves' hyperthyroidism by analysis of genetic markers. Clin Endocrinol 1988: 28: 601-10.
13. Mangklabruks A, Cox N, DeGroot LJ. Genetic factors in autoimmune thyroid disease analyzed by restriction fragment length polymorphisms of candidate genes. J Clin Endocrinol Metab 1991: 73: 236-44.
14. Baldini M, Pappalettera MP, Lecchi L et al. Human lymphocyte antigens in Graves' disease: Correlation with persistent course of disease. Am J Med Sci 1995: 309: 43-8.
15. Cho BY, Rhee BD, Lee DS et al. HLA and Graves' disease in Koreans. Tissue Antigens 1987: 30: 119-21.
16. Dong R-P, Kimura A, Okubo R et al. HLA·A and DBP1 loci confer susceptibility to Graves' disease. Hum Immunol 1992: 35: 165-72.
17. Inoue D, Sato K, Enomoto T, Sugawa H, Maeda M, Inoko H. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations. Clin Endocrinol 1992: 36: 75-82.
18. Cavan DA, Penny MA, Jacobs KH et al. The HLA association with Graves' disease is sex-specific in Hong Kong Chinese subjects. Clin Endocrinol 1994: 40: 63-6.
19. Hawkins BR, Ma JTC, Lam KSL, Wang CCL, Yeung RTT. Association of HLA antigens with thyrotoxic Graves' disease and periodic paralysis in Hong Kong Chinese. Clin Endocrinol 1985: 23: 245-52.
20. Chan SH, Yeo PPB, Lui KF et al. HLA and thyrotoxicosis (Graves' disease) in Chinese. Tissue Antigens 1978: 12: 109-14.
21. Yeo PPB, Cang SH, Thai AC et al. HLA Bw46 and DR9 associations in Graves' disease of Chinese patients are age- and sex-related. Tissue Antigens 1989: 34: 179-84.
22. Tsai KS, Hsieh RP, Chang CC, Chen FW, Lee SC. Association of HLA-DR tissue types with Graves' disease in Taiwan. J Formosan Med Assoc 1989: 188: 336-41.
23. Benjamin R, Parham P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 1990: 11: 137-42.
24. Feltkamp TEW, Khan MA, Lopez de Gastro JA. The pathogenetic role of HLA-B27. Immunol Today 1996: 17: 5-7.
25. Kohn LD, Napolitano G, Singer D et al. Graves' disease: a host defense mechanism gone awry. Intern Rev Immunol 2000: 19: 633-64.
26. Lavard L, Madsen HO, Perrild H et al. Brief communication HLA class II association in juvenile Graves' disease: indication of a strong protective role of the DRB1*0701, DQA1*0201 haplotype. Tissue Antigens 1997: 50: 639-41.
27. Chan SH, Lin YN, Wee GB et al. Human leucocyte antigen DNA typing in Singaporean Chinese patients with Graves' disease. Ann Acad Medical (Singapore) 1993: 22: 576-9.
28. Badenhoop K, Donner H, Braun J, Siegmund T, Ran H, Usadel KH. Genetic markers in diagnosis and prediction of relapse in Graves' disease. Exp Clin Endocrinol Diabetes 1996: 104: 98-100.
29. Ohtsuka K, Nakamura Y. Human leukocyte antigens associated with hyperthyroid Graves' ophthalmopathy in Japanese patients. Am J Ophthalmol 1998: 126: 805-10.
30. Heufelder AE, Smith TJ, Gorman CA, Bahn RS. Increased induction of HLA-DR by interferon-γ in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy. J Clin Endocrinol Metab 1991: 73: 307-13.
31. Heufelder AE, Gorman CA, Bahn RS. Modulation of HLA-DR expression on retroocular fibroblasts from patients with active thyroid-related ophthalmopathy: in vitro effects of agents used in the management of hyperthyroidism and ophthalmopathy. Exp Clin Endocrinol 1991: 97: 206-11.